Infuse Lawsuit May Affect Medtronic Acquisition of Covidien
Class Action Lawsuit Dilemma Medtronic’s $43 billion acquisition of Covidien, which is already controversial, may be influenced by a class action lawsuit over its Infuse bone growth product. According to [...]